YAP1诱导膀癌的进展,并通过IL-6/STAT3通路和CXCL放松调节促进免疫逃避
Pritam Sadhukhan1, Mingxiao Feng2, Emily Illingworth3
1Department of Otolaryngology-Head and Neck Surgery and.
这项研究调查了膀尿癌 (UCB) 中的Hippo途径效应器YAP1,该研究揭示了YAP1驱动了一个免疫抑制瘤免疫微环境 (TIME). YAP1减弱显示了治疗潜力,这表明UCB治疗中YAP1和免疫检查点阻塞的结合.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 河马信号通路对于癌症的发展至关重要.
- YAP1,一个Hippo通路效应器,与瘤发生有关.
- 它在膀皮质癌 (UCB) 的瘤免疫微环境 (TIME) 中的作用仍然在很大程度上未被探索.
研究的目的:
- 研究YAP1在UCB瘤免疫微环境 (TIME) 中的功能.
- 评估在UCB中针对YAP1信号的有效性.
- 探索将YAP1抑制与免疫治疗相结合的潜力.
主要方法:
- 在体外和体内实验中使用遗传和药理学YAP1减弱的实验.
- 鼠标和人类细胞系的RNA测序,以识别YAP1点.
- 对人类样本集的分析,以将YAP1表达与TIME特征相关联.
主要成果:
- YAP1通过IL-6/STAT3途径和化学激素表达来调节时间.
- 减弱YAP1会减少免疫抑制细胞,如M2巨细胞和骨髓细胞衍生的抑制细胞.
- YAP1的表达与癌症干和免疫抑制的时间相关.
结论:
- YAP1信号传递促进癌症干性,并诱导UCB中的免疫抑制时间.
- 准YAP1可以将TIME重新编程到一个抗瘤状态.
- 联合阻断YAP1和免疫检查点可能为UCB患者提供一种新的治疗策略.
更多相关视频
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
09:55All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System
Published on: December 20, 2021
相关概念视频
The Intrinsic Apoptotic Pathway
Induced Pluripotent Stem Cells
Somatic...
Abnormal Proliferation
The JAK-STAT Signaling Pathway
Cancer Cell Migration through Invadopodia
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
